Home › Trial NCT03950102
SBRT as Bridging Therapy for Hepatocellular Carcinoma Patients on Transplant Waitlist
- Trial IDNCT03950102
- StatusUnknown
- PhaseN/A
- Study typeInterventional
- SponsorThe University of Hong Kong
- Enrollment40
- Start date2015-07-01
- ConditionsHepatocellular Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.